Exploring the Molecular Etiology of Dominant-Negative Mutations
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Herskowitz (1987) provided the classical definition of dominant-negative (DN) mutations as those leading to mutant polypeptides that disrupt the activity of the wild-type gene when overexpressed. Although Herskowitz' definition referred basically to intralocus interactions, it is now recognized that interlocus (e.g., trans-acting) interactions can also lead to dominance (Omholt et al., 2000) and to DN effects (DNEs; Veitia 2002). DNEs are thought to have an impact on plant genome evolution. Indeed, Gibson and Spring (1998) have suggested that paralogous genes encoding multidomain proteins might be overretained in polyploids because mutations in such genes could produce DN phenotypes. From a practical viewpoint, DN mutations have been widely used to study gene function in plants, for example, in situations where null mutations of functionally redundant genes result in no phenotype. Here, I explore the mechanistic foundations for DNEs and some of their quantitative aspects to describe the general features of their effects at the molecular level, improved understanding of which should help in the design of DN proteins. Students are accustomed to simplified concepts of dominance and recessivity. These extreme terms stem from the analysis of qualitative characters for which only a few states are scored. More quantitative studies of the phenotypic effects of a mutation have led to proposals for a more exhaustive classification (Müller, 1932). The terms amorph, hypomorph, and hypermorph have been applied to alleles (and gene products) displaying no activity, lower, or higher activity than the wild-type allele, respectively. As noted above, an important source of dominant phenotypes is the production of a mutant protein that interferes with the action of the wild-type one, and alleles producing these DNEs are called antimorphs. The effects of strong antimorphs, such as those reviewed by Herskowitz (1987), can be easily understood. However, the quantitative dimensions of more complex DNEs require further examination in the era of high-throughput genetics and genomics. The simplest examples of DN mutations come from factors that oligomerize, wherein the mutant polypeptide can poison the complex. For instance, in the context of a dimer AA, if the mutant protein a renders dimers Aa and aa inactive (which is easily conceivable, as we will see below), in the heterozygote there will be production of 25% AA, 50% Aa, and 25% aa, leading to only 25% of activity with respect to the wild type. This is to be contrasted with the case of a heterozygous A/- organism (carrying one wild-type and one loss-of-function allele), which is expected to have 50% activity relative to the wild type. This kind of reasoning has led to the proposal that heterozygous DN mutations cause more severe effects than simple null alleles of the same gene (Strachan and Read, 2004). Moreover, if a is overexpressed, the proportion of dimer containing only normal subunits will decrease. Thus, the current shorthand definition of a DN implies that (1) the phenotype of the heterozygote A/a is worse than that of A/- and (2) overexpression of a leads to a stronger phenotype in the heterozygote than when [A] = [a]. A Typical Example of a DN Mutation. Signal transduction system involving a dimeric receptor whose cytoplasmic portion contains a PK domain. Upon interaction with an extracellular ligand, the PK activity of one monomer phosphorylates the cytoplasmic side of the other monomer. If a mutant monomer lacks the cytoplasmic portion, only 25% of the dimeric receptor will work properly, which in most cases is not enough to elicit a normal response. Other examples involve mutations in structural proteins that form polymers (see a general quantitative treatment for multimeric proteins in the Supplemental Materials online). Mutations in such proteins are frequently dominant, and heterozygous individuals carry a mixture of normal and abnormal protein molecules that copolymerize. For example, a missense mutation in the actin 2 gene in Arabidopsis (act2-2D) leads to defects in the initiation and elongation of root hairs, the elongation of root epidermal cells, and growth in aerial portions. Not surprisingly, in transgenic plants overexpressing the mutant gene, actin filament bundles in root epidermal cells are shorter than in the wild type or in the null mutants (Nishimura et al., 2003). DNEs can also arise in newly formed polyploids and hybrids. During allopolyploid and hybrid formation, the parental genomes do not contribute equally to the transcriptome and the proteome of the resulting individual. The alleles contributed by each parent can be expressed at different levels and often encode different isoforms. Thus, a portion of the changes reported in newly formed polyploids and hybrids, either transcriptional or at another phenotypic level (Adams et al., 2003), could be due to DNEs in the context of multimeric complexes. If we consider a protein working as a homodi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The enhanceosome and transcriptional synergy.
Carey, M. (1998) · Cell · doi:10.1016/s0092-8674(00)80893-4 · Cited by 553 · cited 1×
“Synergy is the result of the concerted interactions between the molecules of A already bound to the promoter and the transcriptional machinery (Carey, 1998; Veitia, 2003).”
Background
Cited by
Characterising and Predicting Haploinsufficiency in the Human Genome
Huang, N., Lee, I., Marcotte, E. M., & Hurles, M. E. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001154 · Cited by 647
De Smet, R., Adams, K. L., Vandepoele, K., Van Montagu, M. C. E., Maere, S., & Van de Peer, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300127110 · Cited by 403
Molecular Titration and Ultrasensitivity in Regulatory Networks
Buchler, N. E., & Louis, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.079 · Cited by 260
Buffering of genetic dominance by allele-specific protein complex assembly
Badonyi, M., & Marsh, J. A. (2023) · Science Advances · doi:10.1126/sciadv.adf9845 · Cited by 24
Proteome-scale prediction of molecular mechanisms underlying dominant genetic diseases
(2024) · doi:10.1371/journal.pone.0307312 · Cited by 15
Ferrero, E., Di Gregorio, E., Ferrero, M., Ortolan, E., Moon, Y.-A., Di Campli, A., Pavinato, L., Mancini, C., Tripathy, D., Manes, M., et al. (2023) · Human Genetics · doi:10.1007/s00439-023-02572-y · Cited by 9
Proteome-scale prediction of molecular mechanisms underlying dominant genetic diseases
Badonyi, M., & Marsh, J. A. (2023) · doi:10.1101/2023.09.08.556798 · Cited by 6
Metadata
- Authors
- Veitia, R. A.
- Venue
- The Plant Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-01
- Volume
- 19
- Issue
- 12
- Pages
- 3843-3851
- ISSN
- 1040-4651 (ISSN-L)
- 1532-298X
- OpenAlex
- W2081576851
- Cited by
- 131
- References
- 1
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.